Glucose exposure pattern determines glucagon-like peptide 1 receptor expression and signaling through endoplasmic reticulum stress in rat insulinoma cells

Biochemical and Biophysical Research Communications

Volumn 414, Issue 1, 2011, Pages 220-225

  Cheong, Ye Hwang ^a,b   Kim, Mi Kyung ^a   Son, Moon Ho ^a   Kaang, Bong Kiun ^b  

^a Dong A Pharmaceutical Company   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

ER stress; GLP 1; INS 1 cells; Insulin secretion; Intermittent high glucose

Indexed keywords

BINDING PROTEIN; CASPASE 3; CASPASE 7; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; GLUCOSE; MOLECULAR MARKER;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; CYTOTOXICITY; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVITY; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; INSULIN RELEASE; INSULINOMA; INTRACELLULAR SIGNALING; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION;

ANIMALS; CALCIUM; CELL LINE, TUMOR; ENDOPLASMIC RETICULUM; GLUCOSE; HYPERGLYCEMIA; INSULIN; RATS; RECEPTORS, GLUCAGON; SIGNAL TRANSDUCTION;

RATTUS;

EID: 80054060817     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.09.061     Document Type: Article

References (28)

1. Gerich J.E. Clinical significance, pathogenesis, and management of postprandial hyperglycemia. Arch. Intern. Med. 2003, 163:1306-1316.
2. Legakis I.N., Tzioras C., Phenekos C. Decreased glucagon-like peptide 1 fasting levels in type 2 diabetes. Diabetes Care. 2003, 26:252.
3. 2+ channel activity. Endocrinology 1993, 133:1685-1692.
4. Drucker D.J. The biology of incretin hormones. Cell Metab. 2006, 3:153-165.
5. Girard J. The incretins: from the concept to their use in the treatment of type 2 diabetes. Part A: incretins: concept and physiological functions. Diabetes Metab. 2008, 34:550-559.
6. Favaro E., Miceli I., Bussolati B., Schmitt-Ney M., Cavallo P.P., Camussi G., Zanone M.M. Hyperglycemia induces apoptosis of human pancreatic islet endothelial cells: effects of pravastatin on the Akt survival pathway. Am. J. Pathol. 2008, 173:442-450.
7. Cho J.H., Chang S.A., Kwon H.S., Choi Y.H., Ko S.H., Moon S.D., Yoo S.J., Song K.H., Son H.S., Kim H.S., Lee W.C., Cha B.Y., Son H.Y., Yoon K.H. Long-term effect of the internet-based glucose monitoring system on HbA1c reduction and glucose stability: a 30-month follow-up study for diabetes management with a ubiquitous medical care system. Diabetes Care 2006, 29:2625-2631.
8. Ogata H., Tokuyama K., Nagasaka S., Ando A., Kusaka I., Sato N., Goto A., Shibashi S., Kiyono K., Struzik Z.R., Yamamoto Y. Long-range correlated glucose fluctuations in diabetes. Methods Inf. Med. 2007, 46:222-226.
9. Schisano B., Tripathi G., McGee K., McTernan P.G., Ceriello A. Glucose oscillations, more than constant high glucose, induce p53 activation and a metabolic memory in human endothelial cells. Diabetologia 2011, 54:1219-1226.
10. Piconi L., Quagliaro L., Assaloni R., Da R.R., Maier A., Zuodar G., Ceriello A. Constant and intermittent high glucose enhances endothelial cell apoptosis through mitochondrial superoxide overproduction. Diabetes Metab. Res. Rev. 2006, 22:198-203.
11. Hou Z.Q., Li H.L., Gao L., Pan L., Zhao J.J., Li G.W. Involvement of chronic stresses in rat islet and INS-1 cell glucotoxicity induced by intermittent high glucose. Mol. Cell. Endocrinol. 2008, 291:71-78.
12. Kim M.K., Jung H.S., Yoon C.S., Ko J.H., Jun H.J., Kim T.K., Kwon M.J., Lee S.H., Ko K.S., Rhee B.D., Park J.H. The effect of glucose fluctuation on apoptosis and function of INS-1 pancreatic beta cells. Korean Diabetes J. 2010, 34:47-54.
13. Xu G., Kaneto H., Laybutt D.R., Duvivier-Kali V.F., Trivedi N., Suzuma K., King G.L., Weir G.C., Bonner-Weir S. Downregulation of GLP-1 and GIP receptor expression by hyperglycemia: possible contribution to impaired incretin effects in diabetes. Diabetes 2007, 56:1551-1558.
14. Pan Q.R., Li W.H., Wang H., Sun Q., Xiao X.H., Brock B., Schmitz O. Glucose, metformin, and AICAR regulate the expression of G protein-coupled receptor members in INS-1 beta cell. Horm. Metab. Res. 2009, 41:799-804.
15. Asfari M., Janjic D., Meda P., Li G., Halban P.A., Wollheim C.B. Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cell lines. Endocrinology 1992, 130:167-178.
16. Hamid M., McCluskey J.T., McClenaghan N.H., Flatt P.R. Comparison of the secretory properties of four insulin-secreting cell lines. Endocr. Res. 2002, 28:35-47.
17. Mazze R.S., Strock E., Wesley D., Borgman S., Morgan B., Bergenstal R., Cuddihy R. Characterizing glucose exposure for individuals with normal glucose tolerance using continuous glucose monitoring and ambulatory glucose profile analysis. Diabetes Technol. Ther. 2008, 10:149-159.
18. Ceriello A., Hanefeld M., Leiter L., Monnier L., Moses A., Owens D., Tajima N., Tuomilehto J. Postprandial glucose regulation and diabetic complications. Arch. Intern. Med. 2004, 164:2090-2095.
19. Heine R.J., Balkau B., Ceriello A., Del Prato S., Horton E.S., Taskinen M.R. What does postprandial hyperglycaemia mean?. Diabet. Med. 2004, 21:208-213.
20. Meigs J.B., Nathan D.M., D'Agostino R.B., Wilson P.W. Fasting and postchallenge glycemia and cardiovascular disease risk: The Framingham Offspring Study. Diabetes Care 2002, 25:1845-1850.
21. DECODE Study Group, The European Diabetes Epidemiology Group Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch. Intern. Med. 2001, 163:397-405.
22. Shenton D., Smirnova J.B., Selley J.N., Carroll K., Hubbard S.J., Pavitt G.D., Ashe M.P., Grant C.M. Global translational responses to oxidative stress impact upon multiple levels of protein synthesis. J. Biol. Chem. 2006, 281:29011-29021.
23. Eizirik D.L., Cardozo A.K., Cnop M. The role for endoplasmic reticulum stress in diabetes mellitus. Endocr. Rev. 2008, 29(1):42-61.
24. Hansotia T., Drucker D.J. GIP and GLP-1 as incretin hormones: lessons from single and double incretin receptor knockout mice. Regul. Pept. 2005, 128:125-134.
25. Ahrén B. GLP-1 and extra-islet effects. Horm. Metab. Res. 2004, 36:842-845.
26. Yamazaki H., Zawalich K.C., Zawalich W.S. Desensitization of the pancreatic beta-cell: effects of sustained physiological hyperglycemia and potassium. Am. J. Physiol. Endocrinol. Metab. 2006, 291:H1381-H1387.
27. Tsuboi T., Ravier M.A., Parton L.E., Rutter G.A. Sustained exposure to high glucose concentrations modifies glucose signaling and the mechanics of secretory vesicle fusion in primary rat pancreatic beta-cells. Diabetes 2006, 55:1057-1065.
28. 2+ release in the heart by activation of protein kinase C epsilon and calcium-calmodulin kinase II. J. Biol. Chem. 2009, 284:1514-1522.